# CEFIXIME

NDC: 68180-407
Generic name: CEFIXIME
Labeler / Manufacturer: Lupin Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: POWDER, FOR SUSPENSION
Routes: ORAL
Marketing started: 20150424

FDA application: ANDA065355

## Active ingredients

- CEFIXIME: 200 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68180-407"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68180-407
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d68dbd9-7d75-4ff1-91db-79ff8ae879ec